CONVERGE
Incremental improvements Bring convergence
in bioprocessing will to life in
only take you so far. Augmented Reality
It’s time to converge.
The Life Science Business of Merck
Experience the BioContinuum™ operates as MilliporeSigma in the
Platform, a single environment US and Canada.
where you can leverage a toolbox
of intensified processing and novel
control, integration, and analytical
technologies to unlock
unprecedented possibilities and
transform your bioprocess.
Join the Bioprocessing 4.0
revolution at MerckMillipore.com/BioContinuum
Merck, BioContinuum, Millipore and SAFC are trademarks of Merck KGaA, Darmstadt, Germany
or its affiliates. Detailed information on trademarks is available via publicly accessible resources.
© 2020 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.
Lit. No. MK_AD5346EN V1.0 05/2020.
RNI No. DELENG/2004/13061 Published on 28th of previous month PCW/193/2020-2022
Posting Date: 30th of every month Posted at Ex Servicemen Colony PO, Pune-38
The words you are searching are inside this book. To get more targeted content, please make full-text search by clicking here.
#MAKEINDIACOVID-19FREE
BUILDING INDIGENOUS DIAGNOSTIC CAPABILITIES
India is facing a bigger burden of not having enough diagnostic kits in hand. Specifically, there is a shortage of reagents and consumables required to carry out the diagnostic tests for COVID-19. In order to overcome this burden, India is reaching out to South Korea, USA, Germany and China to arrange for more kits in order to increase the current testing capacity for COVID-19. Although this step might help India to some extent in its current containment plan, the real need can only be fulfilled by accelerating indigenous COVID-19 diagnostics manufacturing.
Discover the best professional documents and content resources in AnyFlip Document Base.
Search